Tufton Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.87M Sell
5,728
-87
-1% -$88.9K 1.15% 31
2026
Q1
$5.35M Sell
5,815
-74
-1% -$75K 0.97% 35
2025
Q4
$6.33M Buy
5,889
+157
+3% +$150K 1.11% 34
2025
Q3
$4.37M Buy
5,732
+986
+21% +$734K 0.78% 45
2025
Q2
$3.7M Sell
4,746
-121
-2% -$94K 0.7% 50
2025
Q1
$4.02M Buy
4,867
+78
+2% +$64.9K 0.77% 48
2024
Q4
$3.7M Buy
4,789
+212
+5% +$176K 0.7% 49
2024
Q3
$4.05M Buy
4,577
+1,110
+32% +$998K 0.76% 45
2024
Q2
$3.14M Buy
3,467
+15
+0.4% +$12K 0.61% 49
2024
Q1
$2.69M Buy
3,452
+1,116
+48% +$794K 0.53% 57
2023
Q4
$1.36M Buy
2,336
+1,896
+431% +$1.11M 0.29% 66
2023
Q3
$236K Hold
440
0.05% 112
2023
Q2
$206K Buy
+440
New +$185K 0.04% 118

Other funds holding LLY

Tufton Capital Management's LLY Position: Q2 2026 in Review

Tufton Capital Management reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $88.9K and leaving 5,728 shares worth $6.87M. The position accounts for 1.15% of the portfolio, ranked #31.

Tufton Capital Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Tufton Capital Management held 5,728 shares of Eli Lilly worth $6.87M as of Q2 2026.
  • Tufton Capital Management sold 87 Eli Lilly shares in Q2 2026, an estimated $88.9K.
  • Eli Lilly made up 1.15% of Tufton Capital Management's portfolio in Q2 2026, its #31 holding.
  • Tufton Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Tufton Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.